STOCK TITAN

[SCHEDULE 13G/A] Helius Medical Technologies, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Helius Medical Technologies (HSDT) received a Schedule 13G/A filed by CVI Investments, Inc. and Heights Capital Management, Inc. The filers state they collectively hold 0 shares, representing 0% of the Class A common stock, and that ownership is at or below the 5% threshold. Heights Capital is identified as the investment manager to CVI and may be deemed to have voting and dispositive power over CVI's shares, while each party disclaims beneficial ownership except for any pecuniary interest.

The filing references a previously filed limited power of attorney and a joint filing agreement and contains no disclosure of an acquisition, disposition, or group control.

Helius Medical Technologies (HSDT) ha ricevuto un Schedule 13G/A presentato da CVI Investments, Inc. e Heights Capital Management, Inc. I dichiarante dichiarano di detenere collettivamente 0 azioni, pari al 0% del capitale sociale di Classe A, e che la partecipazione è uguale o inferiore alla soglia del 5%. Heights Capital è indicata come gestore degli investimenti di CVI e potrebbe essere considerata titolare del potere di voto e del potere dispositvo sulle azioni di CVI, mentre ciascuna parte rinuncia alla qualità di proprietario beneficiario, fatta salva qualsiasi interesse pecuniario.

Il deposito fa riferimento a una procura limitata e a un accordo di deposito congiunto presentati in precedenza e non contiene alcuna comunicazione di acquisizione, cessione o controllo di gruppo.

Helius Medical Technologies (HSDT) recibió un Schedule 13G/A presentado por CVI Investments, Inc. y Heights Capital Management, Inc. Los declarante indican que en conjunto poseen 0 acciones, que representan el 0% de las acciones ordinarias Clase A, y que la participación se encuentra en o por debajo del umbral del 5%. Heights Capital está identificada como el gestor de inversiones de CVI y podría considerarse que tiene poder de voto y poder dispositvo sobre las acciones de CVI, mientras que cada parte renuncia a la titularidad beneficiaria, salvo cualquier interés pecuniario.

La presentación hace referencia a un poder limitado y a un acuerdo de presentación conjunta presentados previamente y no contiene divulgación alguna de una adquisición, disposición o control en grupo.

Helius Medical Technologies (HSDT)는 CVI Investments, Inc.와 Heights Capital Management, Inc.가 제출한 Schedule 13G/A를 접수했습니다. 제출인들은 공동으로 0주를 보유하고 있어 Class A 보통주 중 0%에 해당하며, 보유 비율이 5% 기준 이하임을 명시하고 있습니다. Heights Capital은 CVI의 투자운용사로 기재되어 있으며 CVI의 주식에 대해 의결권 및 처분권을 가지고 있는 것으로 간주될 수 있습니다. 다만 각 당사자는 금전적 이익을 제외한 실질적 소유권(beneficial ownership)을 부인합니다.

이번 제출서는 이전에 제출된 제한 위임장(limited power of attorney) 및 공동 제출 합의서(joint filing agreement)를 참조하고 있으며, 인수·처분 또는 집단적 지배에 대한 공개는 포함하고 있지 않습니다.

Helius Medical Technologies (HSDT) a reçu un Schedule 13G/A déposé par CVI Investments, Inc. et Heights Capital Management, Inc. Les déclarants indiquent détenir collectivement 0 actions, représentant 0% des actions ordinaires de classe A, et que la participation est égale ou inférieure au seuil de 5%. Heights Capital est identifiée comme le gestionnaire d'investissement de CVI et pourrait être réputée disposer du pouvoir de vote et du pouvoir dispositif sur les actions de CVI, tandis que chaque partie décline la qualité de propriétaire bénéficiaire, hormis tout intérêt pécuniaire éventuel.

Le dépôt fait référence à une procuration limitée et à un accord de dépôt conjoint précédemment déposés et ne contient aucune divulgation d'acquisition, de cession ou de contrôle de groupe.

Helius Medical Technologies (HSDT) erhielt ein Schedule 13G/A, das von CVI Investments, Inc. und Heights Capital Management, Inc. eingereicht wurde. Die Melder geben an, gemeinsam 0 Aktien zu halten, was 0% des Class‑A‑Stammkapitals entspricht, und dass die Beteiligung auf oder unter der 5%-Schwelle liegt. Heights Capital wird als Investmentmanager von CVI benannt und kann als Inhaber der Stimm- und Verfügungsbefugnis über die Aktien von CVI angesehen werden, während jede Partei eine wirtschaftliche Eigentümerschaft mit Ausnahme etwaiger finanzieller Interessen bestreitet.

Die Meldung verweist auf eine zuvor eingereichte beschränkte Vollmacht und eine gemeinsame Einreichungsvereinbarung und enthält keine Angaben zu einem Erwerb, einer Veräußerung oder einer Gruppenherrschaft.

Positive
  • Reporting persons disclose 0% ownership of Class A common stock, confirming no significant stake.
  • Filing references a previously filed limited power of attorney and joint filing agreement, documenting the reporting relationship.
Negative
  • None.

Insights

TL;DR: Routine ownership disclosure—reporting parties state zero holdings, so no material change to ownership or investor control.

The Schedule 13G/A confirms that CVI Investments and Heights Capital report 0% ownership of Helius Class A common stock, which is a clear, non-material disclosure for investors. The filing notes the manager-client relationship where Heights Capital serves as investment manager to CVI and may be deemed to have voting/dispositive power over shares owned by CVI, but both entities disclaim beneficial ownership except for pecuniary interest. No acquisition, >5% stake, or group control is reported.

TL;DR: Disclosure clarifies manager-client roles without indicating beneficial ownership or governance influence.

The document provides governance-related clarity: Heights Capital is identified as CVI's investment manager and a previously filed limited power of attorney and joint filing agreement are referenced. These filings document authority relationships but, per the statement, do not evidence beneficial ownership or an intent to influence control. From a governance perspective, this is a routine, neutral disclosure rather than a triggering event.

Helius Medical Technologies (HSDT) ha ricevuto un Schedule 13G/A presentato da CVI Investments, Inc. e Heights Capital Management, Inc. I dichiarante dichiarano di detenere collettivamente 0 azioni, pari al 0% del capitale sociale di Classe A, e che la partecipazione è uguale o inferiore alla soglia del 5%. Heights Capital è indicata come gestore degli investimenti di CVI e potrebbe essere considerata titolare del potere di voto e del potere dispositvo sulle azioni di CVI, mentre ciascuna parte rinuncia alla qualità di proprietario beneficiario, fatta salva qualsiasi interesse pecuniario.

Il deposito fa riferimento a una procura limitata e a un accordo di deposito congiunto presentati in precedenza e non contiene alcuna comunicazione di acquisizione, cessione o controllo di gruppo.

Helius Medical Technologies (HSDT) recibió un Schedule 13G/A presentado por CVI Investments, Inc. y Heights Capital Management, Inc. Los declarante indican que en conjunto poseen 0 acciones, que representan el 0% de las acciones ordinarias Clase A, y que la participación se encuentra en o por debajo del umbral del 5%. Heights Capital está identificada como el gestor de inversiones de CVI y podría considerarse que tiene poder de voto y poder dispositvo sobre las acciones de CVI, mientras que cada parte renuncia a la titularidad beneficiaria, salvo cualquier interés pecuniario.

La presentación hace referencia a un poder limitado y a un acuerdo de presentación conjunta presentados previamente y no contiene divulgación alguna de una adquisición, disposición o control en grupo.

Helius Medical Technologies (HSDT)는 CVI Investments, Inc.와 Heights Capital Management, Inc.가 제출한 Schedule 13G/A를 접수했습니다. 제출인들은 공동으로 0주를 보유하고 있어 Class A 보통주 중 0%에 해당하며, 보유 비율이 5% 기준 이하임을 명시하고 있습니다. Heights Capital은 CVI의 투자운용사로 기재되어 있으며 CVI의 주식에 대해 의결권 및 처분권을 가지고 있는 것으로 간주될 수 있습니다. 다만 각 당사자는 금전적 이익을 제외한 실질적 소유권(beneficial ownership)을 부인합니다.

이번 제출서는 이전에 제출된 제한 위임장(limited power of attorney) 및 공동 제출 합의서(joint filing agreement)를 참조하고 있으며, 인수·처분 또는 집단적 지배에 대한 공개는 포함하고 있지 않습니다.

Helius Medical Technologies (HSDT) a reçu un Schedule 13G/A déposé par CVI Investments, Inc. et Heights Capital Management, Inc. Les déclarants indiquent détenir collectivement 0 actions, représentant 0% des actions ordinaires de classe A, et que la participation est égale ou inférieure au seuil de 5%. Heights Capital est identifiée comme le gestionnaire d'investissement de CVI et pourrait être réputée disposer du pouvoir de vote et du pouvoir dispositif sur les actions de CVI, tandis que chaque partie décline la qualité de propriétaire bénéficiaire, hormis tout intérêt pécuniaire éventuel.

Le dépôt fait référence à une procuration limitée et à un accord de dépôt conjoint précédemment déposés et ne contient aucune divulgation d'acquisition, de cession ou de contrôle de groupe.

Helius Medical Technologies (HSDT) erhielt ein Schedule 13G/A, das von CVI Investments, Inc. und Heights Capital Management, Inc. eingereicht wurde. Die Melder geben an, gemeinsam 0 Aktien zu halten, was 0% des Class‑A‑Stammkapitals entspricht, und dass die Beteiligung auf oder unter der 5%-Schwelle liegt. Heights Capital wird als Investmentmanager von CVI benannt und kann als Inhaber der Stimm- und Verfügungsbefugnis über die Aktien von CVI angesehen werden, während jede Partei eine wirtschaftliche Eigentümerschaft mit Ausnahme etwaiger finanzieller Interessen bestreitet.

Die Meldung verweist auf eine zuvor eingereichte beschränkte Vollmacht und eine gemeinsame Einreichungsvereinbarung und enthält keine Angaben zu einem Erwerb, einer Veräußerung oder einer Gruppenherrschaft.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G



CVI Investments, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Date:08/12/2025
Heights Capital Management, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary
Date:08/12/2025

Comments accompanying signature: Heights Capital Management, Inc. serves as authorized agent of CVI Investments, Inc. pursuant to a Limited Power of Attorney, a copy of which was previously filed.
Exhibit Information

EXHIBIT INDEX EXHIBIT DESCRIPTION ________ ________ I Limited Power of Attorney* II Joint Filing Agreement* * Previously filed

FAQ

Who filed the Schedule 13G/A for Helius (HSDT)?

The statement was filed by CVI Investments, Inc. and Heights Capital Management, Inc.

How many Helius (HSDT) shares do the reporting persons beneficially own?

They report 0 shares, representing 0% of the Class A common stock.

Does Heights Capital have voting or dispositive power over CVI's Helius shares?

Yes, the filing states Heights Capital is the investment manager to CVI and may be deemed to have voting and dispositive power over shares owned by CVI, though the parties disclaim beneficial ownership except for any pecuniary interest.

Is the reported ownership above the 5% threshold for Helius (HSDT)?

No. The filing confirms ownership is 0%, which is below the 5% threshold.

Were any supporting documents or exhibits referenced?

Yes. The filing references a previously filed Limited Power of Attorney and a Joint Filing Agreement.
Helius Med Technologies Inc

NASDAQ:HSDT

HSDT Rankings

HSDT Latest News

HSDT Latest SEC Filings

HSDT Stock Data

4.13M
672.94k
1.64%
0.75%
4.63%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEWTOWN